April 11, 2018 / 6:50 AM / 3 months ago

BRIEF-Chugai Pharmaceutical says waiver of claims in patent infringement lawsuit

April 11 (Reuters) - Chugai Pharmaceutical Co Ltd

* Says it has decided to waive its claim in a patent infringement lawsuit against Nippon Kayaku Co Ltd

* Says co filed a lawsuit to the Tokyo District Court on Aug. 17, 2017, demanding the suspension of manufacturing and distribution of the biosimilar of anti-HER2 monoclonal antibody Herceptin® Injection 60 and 150 (Herceptin® Injection) against Nippon Kayaku, the applicant for marketing approval of the biosimilar of Herceptin® Injection, citing such party’s infringement of the application patents for the treatment of breast cancer owned by Genentech Inc

Source text in Japanese: goo.gl/7AQ1Qc

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below